Cancer drug prediction has yet to embrace the open-source movement, Georgia Tech researchers write. This week, they made public a machine learning platform that has built predictive models for 9 drugs. They don't care if people make money off the algorithm, as long as they advance treatments.

See the source article by following the link below:
Cancer drug prediction has yet to embrace the open-source movement, Georgia Tech researchers write. This week, they made public a machine learning platform that has built predictive models for 9 drugs. They don't care if people make money off the algorithm, as long as they advance treatments.